This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 May;15(6):550-2.

doi: 10.1016/S1470-2045(14)70116-0. Epub 2014 Mar 20.

Can NOAH guide us to improved survival in breast cancer?

Stephen R D Johnston¹

Affiliations

PMID: 24657002
DOI: 10.1016/S1470-2045(14)70116-0

Comment

Can NOAH guide us to improved survival in breast cancer?

Stephen R D Johnston. Lancet Oncol. 2014 May.

. 2014 May;15(6):550-2.

doi: 10.1016/S1470-2045(14)70116-0. Epub 2014 Mar 20.

Author

Stephen R D Johnston¹

Affiliation

¹ The Breast Unit, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK. Electronic address: stephen.johnston@rmh.nhs.uk.

PMID: 24657002
DOI: 10.1016/S1470-2045(14)70116-0

No abstract available

PubMed Disclaimer

Comment on

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.
Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, Moliterni A, Vazquez F, Byakhov MJ, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Magazzù D, Heinzmann D, Steinseifer J, Valagussa P, Baselga J. Gianni L, et al. Lancet Oncol. 2014 May;15(6):640-7. doi: 10.1016/S1470-2045(14)70080-4. Epub 2014 Mar 20. Lancet Oncol. 2014. PMID: 24657003 Clinical Trial.

Similar articles

Neoadjuvant trastuzumab for breast cancer. Better to stick with proven treatments.
[No authors listed] [No authors listed] Prescrire Int. 2013 Feb;22(135):39. Prescrire Int. 2013. PMID: 23444499 Review.
Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer.
Chang HR. Chang HR. Cancer. 2010 Jun 15;116(12):2856-67. doi: 10.1002/cncr.25120. Cancer. 2010. PMID: 20564392 Review.
Subcutaneous trastuzumab (Herceptin) injection shows promise.
[No authors listed] [No authors listed] Oncology (Williston Park). 2012 Sep;26(9):873. Oncology (Williston Park). 2012. PMID: 23061348 No abstract available.
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V, Eiermann W, Zambetti M, Manikhas A, Bozhok A, Lluch A, Tjulandin S, Sabadell MD, Caballero A, Valagussa P, Baselga J, Gianni L. Semiglazov V, et al. Eur J Surg Oncol. 2011 Oct;37(10):856-63. doi: 10.1016/j.ejso.2011.07.003. Epub 2011 Aug 16. Eur J Surg Oncol. 2011. PMID: 21843921 Clinical Trial.
Neoadjuvant anthracycline and trastuzumab for breast cancer: is concurrent treatment safe?
Bozovic-Spasojevic I, Azim HA Jr, Paesmans M, Suter T, Piccart MJ, de Azambuja E. Bozovic-Spasojevic I, et al. Lancet Oncol. 2011 Mar;12(3):209-11. doi: 10.1016/S1470-2045(11)70013-4. Epub 2011 Feb 25. Lancet Oncol. 2011. PMID: 21354372 No abstract available.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information